Publication:
The combination of pivmecillinam and pivampicillin in the treatment of enteric fever

Simple item page
dc.contributor.authorD. Tanphaichitraen_US
dc.contributor.authorS. Srimuangen_US
dc.contributor.authorP. Chiaprasittigulen_US
dc.contributor.authorP. Mendayen_US
dc.contributor.authorO. E. Christensenen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherLeo Laboratories Limiteden_US
dc.contributor.otherHolbaek Sygehusen_US
dc.date.accessioned2018-10-12T07:42:33Z
dc.date.available2018-10-12T07:42:33Z
dc.date.issued1984-11-01en_US
dc.description.abstractThirty-nine patients with acute enteric fever received the fixed-dose oral combination of pivmecillinam/pivampicillin. Thirty-seven (95%) subjects responded satisfactorily. No relapses or persistent faecal excretion of salmonellae were seen in the 29 patients followed up for 2 to 19 weeks. The treatment was well tolerated, no side-effects being recorded. In vitro studies revealed a synergistic interaction between mecillinam and ampicillin against isolates of Salmonella paratyphi A. © 1984 MMV Medizin Verlag GmbH München.en_US
dc.identifier.citationInfection. Vol.12, No.6 (1984), 381-383en_US
dc.identifier.doi10.1007/BF01645219en_US
dc.identifier.issn14390973en_US
dc.identifier.issn03008126en_US
dc.identifier.other2-s2.0-0021683977en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/30660
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0021683977&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe combination of pivmecillinam and pivampicillin in the treatment of enteric feveren_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0021683977&origin=inwarden_US

Files

Collections

Scopus 1969-1990